GHENT, Belgium — The progression of ankylosing spondylitis can be slowed when tumor necrosis factor (TNF) inhibitors are added to high-dose nonsteroidal anti-inflammatory drugs (NSAIDs), possibly ...

(UPDATED July 25, 2013) — A major observational study in ankylosing spondylitis (AS) published online July 1 in Arthritis & Rheumatism revealed that tumor necrosis factor (TNF) inhibitors ...

Featured in the June 2005 issue of <i>Arthritis & Rheumatism</i>, this study offers hope for decreasing the progression of AS, without increasing the risk of peptic ulcers or other adverse events. A ...

Smoking and multiple epigenetic variables were found to be associated with radiographic progression in patients with ankylosing spondylitis, according to recently published data. A cohort of 76 ...

Advances in medication have changed ankylosing spondylitis treatment and may even change the progression of the disease. That’s welcome news for many people who deal with the pain and stiffness of ...

Physically demanding jobs may increase the effects of inflammation on the progression of ankylosing spondylitis, possibly leading to increased bone formation in these patients, according to new ...

The results of a cohort study presented at the Annual European Congress of Rheumatology (EULAR 2018) showed that, in patients with ankylosing spondylitis (AS) taking tumour necrosis factor (TNF) ...

Please provide your email address to receive an email when new articles are posted on . MADRID — Smoking was associated with accelerated disease progression in patients with ankylosing spondylitis, ...

A sub-study showed up to 80% of ankylosing spondylitis (AS) patients treated with Cosentyx had no radiographic progression in the spine over two years[1] Cosentyx demonstrated a sustained response for ...

Patients with radiographic axial spondyloarthritis (ax-SpA) and a high risk of radiographic progression had similar low progression on both secukinumab and an adalimumab biosimilar. Both secukinumab ...

DUBLIN--(BUSINESS WIRE)--The "Global Ankylosing Spondylitis Clinical Trial Pipeline Highlights - 2019" report has been added to ResearchAndMarkets.com's offering. This report, Ankylosing Spondylitis ...

A widely under-recognized form of arthritis, ankylosing spondylitis (AS) is a chronic, progressive disease targeting the spine. Commonly striking in young adulthood, before age 35, AS causes ...